Join us for an informative webinar exploring the growing public health and clinical concerns surrounding kratom use. Led by Dr. Andrew Kolodny, MD, Medical Director of the Opioid Policy Research Collaborative at Brandeis University, this session will provide an evidence-based overview of kratom, its pharmacology, and its relationship to opioid use disorder.
Participants will learn about:
- The pharmacology of kratom and its principal alkaloids
- Current evidence supporting the classification of kratom as an opioid
- Trends in kratom and opioid use in the United States
- Clinical and public health consequences associated with kratom use
- Evidence-based approaches for patient care and harm reduction
- Current public health and regulatory responses to kratom-related concerns
The webinar will conclude with a live question-and-answer session. This program is offered free of charge and includes continuing education credits for a variety of healthcare professionals.